313 related articles for article (PubMed ID: 31675546)
1. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders.
Kehle-Forbes SM; Chen S; Polusny MA; Lynch KG; Koffel E; Ingram E; Foa EB; Van Horn DHA; Drapkin ML; Yusko DA; Oslin DW
Drug Alcohol Depend; 2019 Dec; 205():107647. PubMed ID: 31675546
[TBL] [Abstract][Full Text] [Related]
2. Study design, interventions, and baseline characteristics for the Substance use and TRauma Intervention for VEterans (STRIVE) trial.
Kehle-Forbes SM; Drapkin ML; Foa EB; Koffel E; Lynch KG; Polusny MA; Van Horn DH; Yusko DA; Charlesworth M; Blasco M; Oslin DW
Contemp Clin Trials; 2016 Sep; 50():45-53. PubMed ID: 27444425
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial.
Kehle-Forbes SM; Nelson D; Norman SB; Schnurr PP; Shea MT; Ackland PE; Meis L; Possemato K; Polusny MA; Oslin D; Hamblen JL; Galovski T; Kenny M; Babajide N; Hagedorn H
Contemp Clin Trials; 2022 Sep; 120():106876. PubMed ID: 35987487
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive predictors of treatment outcomes in psychotherapy for comorbid PTSD and substance use disorders.
Scott JC; Lynch KG; Cenkner DP; Kehle-Forbes SM; Polusny MA; Gur RC; Chen S; Foa EB; Oslin DW
J Consult Clin Psychol; 2021 Nov; 89(11):937-946. PubMed ID: 34881912
[TBL] [Abstract][Full Text] [Related]
5. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.
Back SE; Killeen T; Badour CL; Flanagan JC; Allan NP; Ana ES; Lozano B; Korte KJ; Foa EB; Brady KT
Addict Behav; 2019 Mar; 90():369-377. PubMed ID: 30529244
[TBL] [Abstract][Full Text] [Related]
6. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes?
Jeffirs SM; Jarnecke AM; Flanagan JC; Killeen TK; Laffey TF; Back SE
Drug Alcohol Depend; 2019 Jun; 199():70-75. PubMed ID: 31009834
[TBL] [Abstract][Full Text] [Related]
7. Written exposure therapy for veterans with co-occurring substance use disorders and PTSD: Study design of a randomized clinical trial.
Meshberg-Cohen S; Cook JM; Bin-Mahfouz A; Petrakis IL
Contemp Clin Trials; 2024 Apr; 139():107475. PubMed ID: 38365173
[TBL] [Abstract][Full Text] [Related]
8. Treatment of co-occurring posttraumatic stress disorder and substance use: Does order of onset influence outcomes?
Bountress KE; Badour C; Flanagan J; Gilmore AK; Back SE
Psychol Trauma; 2018 Nov; 10(6):662-665. PubMed ID: 28771018
[TBL] [Abstract][Full Text] [Related]
9. The role of posttraumatic guilt and anger in integrated treatment for PTSD and co-occurring substance use disorders among primarily male veterans.
Saraiya TC; Badour CL; Jones AC; Jarnecke AM; Brown DG; Flanagan JC; Killeen TK; Back SE
Psychol Trauma; 2023 Nov; 15(8):1293-1298. PubMed ID: 35025558
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Integrated Exposure Therapy vs Integrated Coping Skills Therapy for Comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A Randomized Clinical Trial.
Norman SB; Trim R; Haller M; Davis BC; Myers US; Colvonen PJ; Blanes E; Lyons R; Siegel EY; Angkaw AC; Norman GJ; Mayes T
JAMA Psychiatry; 2019 Aug; 76(8):791-799. PubMed ID: 31017639
[TBL] [Abstract][Full Text] [Related]
11. Psychotherapy for Military-Related PTSD: A Review of Randomized Clinical Trials.
Steenkamp MM; Litz BT; Hoge CW; Marmar CR
JAMA; 2015 Aug; 314(5):489-500. PubMed ID: 26241600
[TBL] [Abstract][Full Text] [Related]
12. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.
Ruglass LM; Lopez-Castro T; Papini S; Killeen T; Back SE; Hien DA
Psychother Psychosom; 2017; 86(3):150-161. PubMed ID: 28490022
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Controlled Trial for Veterans with PTSD and Substance Use Disorder: Creating Change versus Seeking Safety.
Najavits LM; Krinsley K; Waring ME; Gallagher MW; Skidmore C
Subst Use Misuse; 2018 Sep; 53(11):1788-1800. PubMed ID: 29461920
[TBL] [Abstract][Full Text] [Related]
14. Temporal dynamics of symptom change among veterans receiving an integrated treatment for posttraumatic stress disorder and substance use disorders.
Badour CL; Flanagan JC; Allan NP; Gilmore AK; Gros DF; Killeen T; Korte KJ; Brown DG; Kolnogorova K; Back SE
J Trauma Stress; 2022 Apr; 35(2):546-558. PubMed ID: 34773928
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Prolonged Exposure vs Cognitive Processing Therapy for Treatment of Posttraumatic Stress Disorder Among US Veterans: A Randomized Clinical Trial.
Schnurr PP; Chard KM; Ruzek JI; Chow BK; Resick PA; Foa EB; Marx BP; Friedman MJ; Bovin MJ; Caudle KL; Castillo D; Curry KT; Hollifield M; Huang GD; Chee CL; Astin MC; Dickstein B; Renner K; Clancy CP; Collie C; Maieritsch K; Bailey S; Thompson K; Messina M; Franklin L; Lindley S; Kattar K; Luedtke B; Romesser J; McQuaid J; Sylvers P; Varkovitzky R; Davis L; MacVicar D; Shih MC
JAMA Netw Open; 2022 Jan; 5(1):e2136921. PubMed ID: 35044471
[TBL] [Abstract][Full Text] [Related]
16. Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders?
Lancaster CL; Gros DF; Mullarkey MC; Badour CL; Killeen TK; Brady KT; Back SE
Behav Cogn Psychother; 2020 Jan; 48(1):38-53. PubMed ID: 31010449
[TBL] [Abstract][Full Text] [Related]
17. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout.
Szafranski DD; Snead A; Allan NP; Gros DF; Killeen T; Flanagan J; Pericot-Valverde I; Back SE
Addict Behav; 2017 Oct; 73():30-35. PubMed ID: 28460246
[TBL] [Abstract][Full Text] [Related]
18. Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment.
Brown DG; Flanagan JC; Jarnecke A; Killeen TK; Back SE
J Ethn Subst Abuse; 2022; 21(3):1141-1164. PubMed ID: 33111647
[TBL] [Abstract][Full Text] [Related]
19. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders.
Back SE; McCauley JL; Korte KJ; Gros DF; Leavitt V; Gray KM; Hamner MB; DeSantis SM; Malcolm R; Brady KT; Kalivas PW
J Clin Psychiatry; 2016 Nov; 77(11):e1439-e1446. PubMed ID: 27736051
[TBL] [Abstract][Full Text] [Related]
20. Lagged effects of substance use on PTSD severity in a randomized controlled trial with modified prolonged exposure and relapse prevention.
Hien DA; Smith KZ; Owens M; López-Castro T; Ruglass LM; Papini S
J Consult Clin Psychol; 2018 Oct; 86(10):810-819. PubMed ID: 30265040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
